|
SNUPN expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 8.35860000000244E-05 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.216480E-03 |
| Normal-vs-Stage2 |
7.739200E-03 |
| Normal-vs-Stage3 |
3.327399999975E-06 |
| Normal-vs-Stage4 |
5.546100E-02 |
| Stage1-vs-Stage2 |
7.421200E-01 |
| Stage1-vs-Stage3 |
2.612100E-02 |
| Stage1-vs-Stage4 |
8.114200E-01 |
| Stage2-vs-Stage3 |
2.232600E-01 |
| Stage2-vs-Stage4 |
6.564600E-01 |
| Stage3-vs-Stage4 |
9.859800E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.30350000000046E-05 |
| Normal-vs-AfricanAmerican |
4.398800E-01 |
| Normal-vs-Asian |
6.622400E-02 |
| Caucasian-vs-AfricanAmerican |
2.521800E-02 |
| Caucasian-vs-Asian |
8.372600E-01 |
| AfricanAmerican-vs-Asian |
2.468400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.87809999999877E-05 |
| Normal-vs-Female |
4.983700E-03 |
| Male-vs-Female |
1.722450E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
5.620900E-03 |
| Normal-vs-Age(41-60Yrs) |
2.564500E-03 |
| Normal-vs-Age(61-80Yrs) |
8.27460000000224E-05 |
| Normal-vs-Age(81-100Yrs) |
1.102140E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.109400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.095400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
8.928200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.880000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.316800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.472000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
1.230560E-01 |
| Normal-vs-Grade 2 |
4.183300E-03 |
| Normal-vs-Grade 3 |
1.46430000003139E-06 |
| Normal-vs-Grade 4 |
2.315600E-02 |
| Grade 1-vs-Grade 2 |
8.385900E-04 |
| Grade 1-vs-Grade 3 |
3.8902999999979E-05 |
| Grade 1-vs-Grade 4 |
1.218930E-03 |
| Grade 2-vs-Grade 3 |
1.791630E-02 |
| Grade 2-vs-Grade 4 |
6.837800E-01 |
| Grade 3-vs-Grade 4 |
3.071400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
1.454480E-02 |
| Normal-vs-ccB subtype |
2.04999999975364E-07 |
| ccA subtype-vs-ccB subtype |
9.447100E-04 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
8.14840000000761E-05 |
| Normal-vs-N1 |
8.178400E-01 |
| N0-vs-N1 |
1.640560E-01 |
|
|
